ClinicalTrials.Veeva

Menu

Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence

G

Glostrup University Hospital, Copenhagen

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Urge Urinary Incontinence

Treatments

Drug: botulinum toxin type A

Study type

Interventional

Funder types

Other

Identifiers

NCT00770406
BTXA2008

Details and patient eligibility

About

A pilot study to examine efficacy and safety of intravesical botulinum toxin type A.

Enrollment

20 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • refractory urge urinary incontinence

Exclusion criteria

  • neurological disease
  • pregnant or lactating
  • bladder neoplasias

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Soren Brostrom, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems